77 results
8-K
BPTH
Bio-Path Holdings Inc
8 Jan 15
Bio-Path Holdings to Present at the Biotech Showcase™ 2015 Conference
12:00am
on January 7, 2015 titled, “Bio-Path Holdings’ Liposomal Grb-2 Featured in Peer-Reviewed Journal ‘Expert Opinion on Drug Delivery.’” A copy of such press
8-K
EX-99.2
BPTH
Bio-Path Holdings Inc
8 Jan 15
Bio-Path Holdings to Present at the Biotech Showcase™ 2015 Conference
12:00am
Exhibit 99.2
Bio-Path Holdings’ Liposomal Grb-2 Featured in Peer-Reviewed Journal “Expert Opinion on Drug Delivery”
HOUSTON, TX, January 7, 2015
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
15 Nov 18
Bio-path Holdings Reports Third Quarter 2018 Financial Results
7:05am
Board.In August 2018, Bio-Path appointed Dr. Fleming, a world-leading gastrointestinal cancer expert, to its SAB. Dr. Fleming offers substantial
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
3 Apr 12
Bio-Path Holdings Reports Fiscal Year 2011
12:00am
. As an expert in liposomal antisense therapeutics and a key member of the research team that performed the basic research and preclinical development
DEFR14A
eeu68m muy1be
23 Sep 10
Revised proxy
12:00am
8-K
EX-10.1
4k7obyr26vovqicrc
16 Apr 15
Entry into a Material Definitive Agreement
12:00am
424B3
d28gvr1wq5ck
16 Aug 11
Prospectus supplement
12:00am
424B3
jpz58ytl
15 May 12
Prospectus supplement
12:00am
424B3
valdlm8agot71 5cjhmb
15 Aug 12
Prospectus supplement
12:00am